Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRI Mapping Techniques for High Grade Brain Lesions
NCT04132843Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jan 2020
- Primary completion
- Sep 2022
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by University of Texas MD Anderson Cancer Center. Primary endpoints: Differences in T2 spin parameters between peritumoral area and normal brain and Differences between peritumoral and normal brain T2 parameters before and after treatment at 120 days. Started Jan 2020; status: completed.
Beyond the preview
Go deeper on NCT04132843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04132843.